CHE241220P480000
- 4.01
- 0.000.00%
Chemed Newsroom
Are Investors Undervaluing Chemed Corporation (NYSE:CHE) By 26%?
Stocks Ex-Dividend November 18
BofA Securities Maintains Chemed(CHE.US) With Buy Rating, Maintains Target Price $708
Chemed To Go Ex-Dividend On November 18th, 2024 With 0.5 USD Dividend Per Share
Express News | Chemed : Repurchases Will Be Funded Through Cash Generated From Ops, Utilization of Revolving Credit Facility
Press Release: Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 50 Cents
Chemed Corporation Board Of Directors Authorizes An Additional $300 Million For Stock Repurchase And Declares Quarterly Dividend Of 50 Cents >CHE
Express News | Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 50 Cents
Chemed Corporation to Present at the UBS 2024 Global Healthcare Conference
Chemed Analyst Ratings
RBC Capital Maintains Chemed(CHE.US) With Buy Rating, Cuts Target Price to $633
RBC Capital Remains a Buy on Chemed (CHE)
Express News | Chemed Corp : RBC Cuts Target Price to $633 From $697
Chemed | 10-Q: Q3 2024 Earnings Report
Analyst Estimates: Here's What Brokers Think Of Chemed Corporation (NYSE:CHE) After Its Third-Quarter Report
Earnings Call: Chemed Reports Mixed Q3 Results, VITAS Growth Amid Roto-Rooter Dip
If EPS Growth Is Important To You, Chemed (NYSE:CHE) Presents An Opportunity
We Ran A Stock Scan For Earnings Growth And Chemed (NYSE:CHE) Passed With Ease
Q3 2024 Chemed Corp Earnings Call
Chemed Corporation (CHE) Q3 2024 Earnings Call Transcript Summary